Krsnaa Diagnostics (NSE:KRSNAA) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
71 GF Score
Price ₹537.05
GF Value ₹898.08
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Research & Development?

Krsnaa Diagnostics NSE:KRSNAA -0.22% 71 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹898.08 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Krsnaa Diagnostics's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Krsnaa Diagnostics  (NSE:KRSNAA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Krsnaa Diagnostics Research & Development Related Terms

Krsnaa Diagnostics Research & Development Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Research & Development Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Krsnaa Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:KRSNAA
71GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Krsnaa Diagnostics and its competitors.
Is Krsnaa Diagnostics' Research & Development too high?
Krsnaa Diagnostics' current Research & Development is ₹0 Mil. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Research & Development compare to TMO and DHR?
Krsnaa Diagnostics' Research & Development of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹898.08, compared to a current price of ₹537.05 — trading 40.2% below its estimated fair value. The current Research & Development is ₹0 Mil. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹537.05 is trading 40.2% below its estimated GF Value™ of ₹898.08. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹898.08 vs. price of ₹537.05 (40.2% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score

Get the complete analysis for NSE:KRSNAA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹537.05
Price
₹898.08
GF Value